Browsing: Investors

Once-a-month shot delivers meaningful weight loss, but Wall Street remains uneasy about competition, tolerability and timing. Pfizer’s obesity moment finally…

Cardiff Oncology (NASDAQ: CRDF) this past week trumpeted positive data via press release from a Phase II trial of its…

As Eli Lilly (NYSE: LLY) and Novo Nordisk (Nasdaq Copenhagen: NOVO-B) scramble to bring an oral glucagon-like peptide 1 (GLP-1)…

By stepping out as the first biopharma to win a three-year “grace period” exemption from President Donald Trump’s earlier-announced plans…

Kapoose Creek Bio’s unique fungal collection is analysed on site at the company’s research station on Vancouver Island in Canada.Credit:…

Prime Medicine (NASDAQ: PRME) has had a lot to celebrate in recent months, explaining a surge that has seen the…